Eqitx to raise $1.8 million
By Melissa Trudinger
Tuesday, 07 December, 2004
Tuesday, 07 December, 2004
Melbourne-based biotech managed investment group EQiTX (ASX: EQX) will ask shareholders to approve a AUD$1.8 million capital raising to provide working capital for its two projects ZingoTX and VacTX.
The placement, involving the issue of six million new shares at $0.30 plus two million free attaching options with an exercise price of $0.20, is to be underwritten by Cunningham Securities.
Related News
Immune cell boost could enable lasting vaccine protection
A research team has found a promising new way to enhance the effectiveness of vaccines by tapping...
Genes influence when babies start walking
Genetics accounts for about a quarter of the differences in when children take their first steps,...
Novel glycopeptide antibiotic candidate shows promise
Researchers have discovered a new type of glycopeptide antibiotic known as saarvienin A, found to...
